-
Big Pharma’s Drug Studies Are Getting a NASA-Style Makeover
firstwordpharma
January 28, 2019
Approximately a third of drug development costs come from clinical trials, and Novartis is looking to make them faster and less expensive, reported Boomberg.
-
Big Pharma’s Drug Studies Are Getting a NASA-Style Makeover
firstwordpharma
January 28, 2019
Approximately a third of drug development costs come from clinical trials, and Novartis is looking to make them faster and less expensive, reported Boomberg.
-
Novartis and University of Oxford partner on AI-based drug development
pharmaceutical-technology
January 22, 2019
Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) and advanced analytics.....
-
Terns Pharmaceuticals Announces the Appointment of Chief Medical Officer
americanpharmaceuticalreview
January 21, 2019
Terns Pharmaceuticals announced the appointment of Erin Quirk, M.D. as Chief Medical Officer (CMO). Dr. Quirk brings more than two decades of clinical medicine and drug development experience....
-
AZ’s chief medical officer Bohen quits after shake-up
pharmaphorum
January 15, 2019
AstraZeneca’s chief medical officer Sean Bohen is to leave the company following its organisational shake-up.
-
China’s Antengene raises $120m to boost drug development
pharmaceutical-technology
January 03, 2019
Chinese biopharmaceutical firm Antengene has raised $120m in a series B funding round led by Boyu Capital and FountainVest to support the development and commercialisation of new therapeutics.....
-
FDA hails 2018 as bumper year for drug development successes
fiercebiotech
December 26, 2018
The FDA has hailed 2018 as a standout year for drug development and approvals, both in terms of the quantity and quality of activity.....
-
Sandoz and Ares Genetics partner to develop anti-infectives platform
pharmaceutical-technology
December 19, 2018
Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to support drug development and life cycle management.....
-
Charles River and Distributed Bio Enter Exclusive Partnership
pharmafocusasia
November 28, 2018
Charles River Laboratories International, Inc today announced that it has entered into an exclusive partnership with Distributed Bio, Inc., a leader in the computational design and optimization of antibody discovery platforms.....
-
Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm (Shanghai) for Global Drug Development
pharmafocusasia
November 27, 2018
Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development....